XML 52 R37.htm IDEA: XBRL DOCUMENT
v3.21.2

Revenues - Summary of Total Net Revenues by Product Line (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended
--- | --- | ---
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020
Disaggregation Of Revenue [Line Items] |  |  |  |
Net revenues | $ 53,917 | $ 48,011 | $ 170,106 | $ 108,866
Product and Services Revenues [Member] |  |  |  |
Disaggregation Of Revenue [Line Items] |  |  |  |
Net revenues | 53,229 | 46,749 | 165,549 | 105,972
Product and Services Revenues [Member] | Infectious Disease Testing [Member] |  |  |  |
Disaggregation Of Revenue [Line Items] |  |  |  |
Net revenues | 12,932 | 13,224 | 39,664 | 36,625
Product and Services Revenues [Member] | Risk Assessment Testing [Member] |  |  |  |
Disaggregation Of Revenue [Line Items] |  |  |  |
Net revenues | 2,674 | 2,253 | 7,265 | 6,786
Product and Services Revenues [Member] | Genomics [Member] |  |  |  |
Disaggregation Of Revenue [Line Items] |  |  |  |
Net revenues | 19,018 | 8,454 | 49,333 | 23,224
Product and Services Revenues [Member] | Microbiome [Member] |  |  |  |
Disaggregation Of Revenue [Line Items] |  |  |  |
Net revenues | 1,693 | 1,530 | 5,888 | 3,869
Product and Services Revenues [Member] | COVID-19 [Member] |  |  |  |
Disaggregation Of Revenue [Line Items] |  |  |  |
Net revenues | 13,930 | 18,867 | 54,147 | 27,918
Product and Services Revenues [Member] | Laboratory Services [Member] |  |  |  |
Disaggregation Of Revenue [Line Items] |  |  |  |
Net revenues | 2,406 | 2,280 | 8,017 | 6,798
Product and Services Revenues [Member] | Other Product and Service Revenues [Member] |  |  |  |
Disaggregation Of Revenue [Line Items] |  |  |  |
Net revenues | 576 | 141 | 1,235 | 752
Other [Member] |  |  |  |
Disaggregation Of Revenue [Line Items] |  |  |  |
Net revenues | 688 | 1,262 | 4,557 | 2,894
Other [Member] | Royalty Income [Member] |  |  |  |
Disaggregation Of Revenue [Line Items] |  |  |  |
Net revenues | 500 | 450 | 2,636 | 1,623
Other [Member] | Other Non Product Revenues [Member] |  |  |  |
Disaggregation Of Revenue [Line Items] |  |  |  |
Net revenues | $ 188 | $ 812 | $ 1,921 | $ 1,271

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 924 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=osur_InfectiousDiseaseTestingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=osur_RiskAssessmentTestingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=osur_GenomicsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=osur_MicrobiomeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=osur_COVID19Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=osur_LaboratoryServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=osur_OtherProductAndServiceRevenuesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=osur_RoyaltyIncomeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=osur_OtherNonProductRevenuesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |